Back to top
more

Molina Healthcare (MOH)

(Delayed Data from NYSE)

$341.27 USD

341.27
891,554

-9.46 (-2.70%)

Updated Jul 31, 2024 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 21% (53 out of 251)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Why Is Molina (MOH) Down 7.9% Since Last Earnings Report?

by Zacks Equity Research

Molina (MOH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

If You Invested $1000 in Molina a Decade Ago, This is How Much It'd Be Worth Now

by Zacks Equity Research

Holding on to popular or trending stocks for the long-term can make your portfolio a winner.

Here's Why You Should Hold Molina (MOH) in Your Portfolio

by Zacks Equity Research

Molina's (MOH) inorganic growth activities, financial flexibility and well-performing Medicaid and Medicare segments poise it for growth.

Here's Why Molina (MOH) is a Strong Value Stock

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

by Zacks Equity Research

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Ensign Group (ENSG) Beats on Q1 Earnings, Hikes '23 EPS View

by Zacks Equity Research

Ensign Group's (ENSG) first-quarter results benefit from growing skilled services revenues. Management estimates EPS of $4.64-$4.77 for this year, higher than the earlier mentioned $4.60-$4.74.

Molina Healthcare (MOH) Beats on Q1 Earnings, Ups '23 EPS View

by Zacks Equity Research

Molina Healthcare's (MOH) Q1 results reflect strong performance in the Medicaid and Medicare segments. Meanwhile, the elevated expense level partially offset the positives.

Molina (MOH) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

While the top- and bottom-line numbers for Molina (MOH) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Molina (MOH) Q1 Earnings Beat Estimates

by Zacks Equity Research

Molina (MOH) delivered earnings and revenue surprises of 13.26% and 1.04%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

What's in Store for Molina Healthcare (MOH) in Q1 Earnings?

by Zacks Equity Research

Molina Healthcare's (MOH) Q1 results are likely to have benefited from the strong performance of its Medicaid and Medicare businesses, partly offset by rising operating costs.

Molina (MOH) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Molina (MOH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

UnitedHealth Group (UNH) Q1 Earnings and Revenues Beat Estimates

by Zacks Equity Research

UnitedHealth (UNH) delivered earnings and revenue surprises of 0.32% and 2.92%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Why Molina (MOH) is a Top Value Stock for the Long-Term

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's Why You Should Retain Molina (MOH) in Your Portfolio

by Zacks Equity Research

Molina's (MOH) inorganic growth activities, financial flexibility and cost-cutting initiatives poise it well for growth.

Zacks Industry Outlook Highlights UnitedHealth, The Cigna, Humana, Centene and Molina Healthcare

by Zacks Equity Research

UnitedHealth, The Cigna, Humana, Centene and Molina Healthcare are part of the Zacks Industry Outlook article.

Debasmita Chatterjee headshot

5 HMO Stocks to Watch Despite Elevated Tech Costs, Nursing Shortage

by Debasmita Chatterjee

Improved premiums cropping from a solid customer base might aid the Medical-HMO industry. However, an escalating expense level and an acute shortage of nurses are roadblocks. Stocks like UNH, CI, HUM, CNC and MOH are likely to navigate the industry storms.

Molina (MOH) Down 12.3% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Molina (MOH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Tenet (THC) Q4 Earnings Beat on Ambulatory Care Strength

by Zacks Equity Research

Tenet Healthcare's (THC) bottom line deteriorates due to higher operating expenses, partially offset by an improving Ambulatory Care segment.

Encompass Health's (EHC) Shares Up 3% on Q4 Earnings Beat

by Zacks Equity Research

Encompass Health's (EHC) fourth-quarter results reflect growing patient volumes and reimbursement rates. Management expects 2023 adjusted EPS within $2.87-$3.16, higher than $2.85 in 2022.

Molina Healthcare (MOH) Q4 Earnings Beat on Solid Medicaid Unit

by Zacks Equity Research

Molina Healthcare's (MOH) fourth-quarter results benefit from its strong Medicaid and Medicare businesses. Management expects 2023 adjusted EPS at a minimum of $19.75.

Here's What Key Metrics Tell Us About Molina (MOH) Q4 Earnings

by Zacks Equity Research

Although the revenue and EPS for Molina (MOH) give a sense of how its business performed in the quarter ended December 2022, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Molina (MOH) Tops Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Molina (MOH) delivered earnings and revenue surprises of 0.99% and 4.57%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Molina (MOH) to Post Q4 Earnings: What You Should Expect

by Zacks Equity Research

Molina Healthcare's (MOH) fourth-quarter results are likely to reflect growth in premiums and Investment income.

Molina (MOH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

Molina (MOH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.